Dear Doctor - Participate in the Survey on fecal microbiota transplantation "Fecal microbiota transplantation (FMT) is a procedure in which stool from a healthy donor is transplanted into the gastrointestinal tract of a person with a gut disorder. The goal of FMT is to restore the composition and function of the gut microbiome.Research on FMT is still in its early stages, but preliminary studies suggest that it may be an effective treatment for a variety of gut disorders, including Clostridium difficile infection (CDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). In addition, because the gut microbiome plays a role in immunity, there is interest in using FMT as a treatment for autoimmune diseases such as Crohn's disease and type 1 diabetes.Side effects of FMT are generally minor and include abdominal pain, bloating, diarrhea, and constipation. However, serious complications have been reported in rare cases, such as sepsis (a potentially life-threatening condition caused by infection).If you are considering FMT for yourself or a loved one, it is important to speak with a healthcare provider who is experienced in this procedure. Participate in Surveys "
1.
Video: Liver transplant for patients with advanced colorectal cancer
2.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
3.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
4.
AI is useful in low-resource areas for triaging breast masses.
5.
Does pollution cause cancer?
1.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
2.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation